P2B-072

State Health Centre Oncology Department (Budapest, Hungary) › P2B-072

P2B-072

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
State Health Centre Oncology Department (Budapest, Hungary) · Dr. Clarke
consented 2013-01-28

completed

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 1 nausea with onset in cycle 6 (2013-05-30); assessed as not related to study drug (not related); resolved 2013-06-02.

mild assessed

Grade 2 ejection fraction decreased with onset in cycle 2 (2013-03-26); assessed as related to study drug (probable); resolved 2013-06-04.

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.